SRAX Balance Sheet Health
Financial Health criteria checks 0/6
Insufficient data to determine the health of SRAX
Key information
n/a
Debt to equity ratio
n/a
Debt
| Interest coverage ratio | n/a |
| Cash | n/a |
| Equity | n/a |
| Total liabilities | n/a |
| Total assets | n/a |
Recent financial health updates
Recent updates
SRAX gets Nasdaq delisting notice, plans to appeal decision
Oct 20Srax receives Nasdaq notice of additional delinquency
Aug 23Is There An Opportunity With SRAX, Inc.'s (NASDAQ:SRAX) 50% Undervaluation?
Aug 18
SRAX announces $9.5M revolving credit facility
Aug 15Is SRAX (NASDAQ:SRAX) A Risky Investment?
Dec 06SRAX Offers Value Here
Nov 29Does SRAX (NASDAQ:SRAX) Have A Healthy Balance Sheet?
Aug 20SRAX Is Booming, Except The Share Price
Aug 19SRAX Has Plenty Of Room To Run
May 28SRAX trades high on Sequire platform reporting 3M retail investors
Feb 02Does SRAX (NASDAQ:SRAX) Have A Healthy Balance Sheet?
Feb 01SRAX EPS misses by $0.14, beats on revenue
Nov 16Financial Position Analysis
Short Term Liabilities: Insufficient data to determine if SRAX's short term assets cover its short term liabilities.
Long Term Liabilities: Insufficient data to determine if SRAX's short term assets cover its long term liabilities.
Debt to Equity History and Analysis
Debt Level: Insufficient data to calculate SRAX's net debt to equity ratio to determine if it is satisfactory.
Reducing Debt: Insufficient data to determine if SRAX's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: Insufficient data to determine if SRAX's debt is well covered by operating cash flow.
Interest Coverage: Insufficient data to determine if SRAX's interest payments on its debt are well covered by EBIT.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 14:55 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2022/12/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
SRAX, Inc. is covered by 8 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Rindos | Aegis Capital Corporation |
| Michael Crawford | B. Riley Securities, Inc. |
| James McIlree | Chardan Capital Markets, LLC |